These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 16793312)

  • 1. An SopB-mediated immune escape mechanism of Salmonella enterica can be subverted to optimize the performance of live attenuated vaccine carrier strains.
    Link C; Ebensen T; Ständner L; Déjosez M; Reinhard E; Rharbaoui F; Guzmán CA
    Microbes Infect; 2006 Jul; 8(8):2262-9. PubMed ID: 16793312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SopB of Salmonella enterica serovar Typhimurium is a potential DNA vaccine candidate in conjugation with live attenuated bacteria.
    Nagarajan AG; Balasundaram SV; Janice J; Karnam G; Eswarappa SM; Chakravortty D
    Vaccine; 2009 May; 27(21):2804-11. PubMed ID: 19428891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salmonella infection of afferent lymph dendritic cells.
    Chan SS; Mastroeni P; McConnell I; Blacklaws BA
    J Leukoc Biol; 2008 Feb; 83(2):272-9. PubMed ID: 17986631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A sopB deletion mutation enhances the immunogenicity and protective efficacy of a heterologous antigen delivered by live attenuated Salmonella enterica vaccines.
    Li Y; Wang S; Xin W; Scarpellini G; Shi Z; Gunn B; Roland KL; Curtiss R
    Infect Immun; 2008 Nov; 76(11):5238-46. PubMed ID: 18765737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virulence attenuation and live vaccine potential of aroA, crp cdt cya, and plasmid-cured mutants of Salmonella enterica serovar Abortusovis in mice and sheep.
    Uzzau S; Marogna G; Leori GS; Curtiss R; Schianchi G; Stocker BA; Rubino S
    Infect Immun; 2005 Jul; 73(7):4302-8. PubMed ID: 15972523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Characterization of attenuated Salmonella C500 strain with a delta asd mutant and use as an Asd+ balanced-lethal host-vector system].
    Zhao Z; Xu Y; Wu B; Cheng X; Li Y; Tang X; Zhang C; Chen H
    Sheng Wu Gong Cheng Xue Bao; 2009 Jan; 25(1):29-36. PubMed ID: 19441223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of phoP and rpoS mutants of Salmonella enterica serovar Typhi as attenuated typhoid vaccine candidates: virulence and protective immune responses in intranasally immunized mice.
    Lee HY; Cho SA; Lee IS; Park JH; Seok SH; Baek MW; Kim DJ; Lee SH; Hur SJ; Ban SJ; Lee YK; Han YK; Cho YK; Park JH
    FEMS Immunol Med Microbiol; 2007 Nov; 51(2):310-8. PubMed ID: 17725620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic detoxification of an aroA Salmonella enterica serovar Typhimurium vaccine strain does not compromise protection against virulent Salmonella and enhances the immune responses towards a protective malarial antigen.
    McKelvie ND; Khan SA; Karavolos MH; Bulmer DM; Lee JJ; DeMarco R; Maskell DJ; Zavala F; Hormaeche CE; Khan CM
    FEMS Immunol Med Microbiol; 2008 Mar; 52(2):237-46. PubMed ID: 18177343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haloarchaeal gas vesicle nanoparticles displaying Salmonella SopB antigen reduce bacterial burden when administered with live attenuated bacteria.
    DasSarma P; Negi VD; Balakrishnan A; Karan R; Barnes S; Ekulona F; Chakravortty D; DasSarma S
    Vaccine; 2014 Jul; 32(35):4543-4549. PubMed ID: 24950351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of an intracellular-activated promoter for the generation of live Salmonella recombinant vaccines.
    Husseiny MI; Hensel M
    Vaccine; 2005 Apr; 23(20):2580-90. PubMed ID: 15780440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salmonella enterica serovar Choleraesuis derivatives harbouring deletions in rpoS and phoP regulatory genes are attenuated in pigs, and survive and multiply in porcine intestinal macrophages and fibroblasts, respectively.
    Domínguez-Bernal G; Tierrez A; Bartolomé A; Martínez-Pulgarín S; Salguero FJ; Orden JA; de la Fuente R
    Vet Microbiol; 2008 Aug; 130(3-4):298-311. PubMed ID: 18313237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulated antigen expression in live recombinant Salmonella enterica serovar Typhimurium strongly affects colonization capabilities and specific CD4(+)-T-cell responses.
    Bumann D
    Infect Immun; 2001 Dec; 69(12):7493-500. PubMed ID: 11705925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Salmonella enterica type III secretion system effector proteins as carriers for heterologous vaccine antigens.
    Hegazy WA; Xu X; Metelitsa L; Hensel M
    Infect Immun; 2012 Mar; 80(3):1193-202. PubMed ID: 22252866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Salmonella typhimurium genes responsible for interference with peptide presentation on MHC class I molecules: Deltayej Salmonella mutants induce superior CD8+ T-cell responses.
    Qimron U; Madar N; Mittrücker HW; Zilka A; Yosef I; Bloushtain N; Kaufmann SH; Rosenshine I; Apte RN; Porgador A
    Cell Microbiol; 2004 Nov; 6(11):1057-70. PubMed ID: 15469434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative analysis of Salmonella enterica serovar Enteritidis mutants with a vaccine potential.
    Karasova D; Sebkova A; Vrbas V; Havlickova H; Sisak F; Rychlik I
    Vaccine; 2009 Aug; 27(38):5265-70. PubMed ID: 19577637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "Gently rough": the vaccine potential of a Salmonella enterica regulatory lipopolysaccharide mutant.
    Nagy G; Palkovics T; Otto A; Kusch H; Kocsis B; Dobrindt U; Engelmann S; Hecker M; Emödy L; Pál T; Hacker J
    J Infect Dis; 2008 Dec; 198(11):1699-706. PubMed ID: 18922095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Entry and survival of Salmonella typhimurium in dendritic cells and presentation of recombinant antigens do not require macrophage-specific virulence factors.
    Niedergang F; Sirard JC; Blanc CT; Kraehenbuhl JP
    Proc Natl Acad Sci U S A; 2000 Dec; 97(26):14650-5. PubMed ID: 11121065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engineering of a live Salmonella enterica serovar Choleraesuis negative-marker strain that allows serological differentiation between immunised and infected animals.
    Herrero-Gil A; Carrión J; Orden JA; de la Fuente R; Domínguez-Bernal G
    Vet J; 2016 Jul; 213():53-8. PubMed ID: 27240916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapeutic intervention alternatives in cancer, using attenuated live bacterial vectors: Salmonella enterica as a carrier of heterologous molecules].
    Hernández-Luna MA; Luria-Pérez R; Huerta-Yépez S
    Rev Invest Clin; 2013; 65(1):65-73. PubMed ID: 23745445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative immunogenicity of M. hyopneumoniae NrdF encoded in different expression systems delivered orally via attenuated S. typhimurium aroA in mice.
    Chen AY; Fry SR; Forbes-Faulkner J; Daggard GE; Mukkur TK
    Vet Microbiol; 2006 May; 114(3-4):252-9. PubMed ID: 16426773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.